Andrew Berchuck

Research interests

Publications

• NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

  Journal of the National Comprehensive Cancer Network · 2022 · 10.6004/jnccn.2022.0047

• Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2021 · https://doi.org/10.6004/jnccn.2021.0007

• Divergent mutational processes distinguish hypoxic and normoxic tumours

  Nature Communications · 2020 · https://doi.org/10.1038/s41467-019-14052-x

• Shared heritability and functional enrichment across six solid cancers

  Nature Communications · 2019 · https://doi.org/10.1038/s41467-018-08054-4

• NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019

  Journal of the National Comprehensive Cancer Network · 2019 · 10.6004/jnccn.2019.0039

• Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage

  JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy071

• The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers

  Cancer Epidemiology Biomarkers & Prevention · 2016 · https://doi.org/10.1158/1055-9965.epi-16-0106

• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

  Nature Communications · 2016 · https://doi.org/10.1038/ncomms12675

• ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

  JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju149

• Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

  Nature Genetics · 2014 · 10.1038/ng.2931

• Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium

  JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/djt431

• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70404-1

• Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines

  Cancer Research · 2011 · https://doi.org/10.1158/0008-5472.can-11-0247

• Integrated genomic analyses of ovarian carcinoma

  Nature · 2011 · https://doi.org/10.1038/nature10166

• A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.668

• A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

  Nature Genetics · 2009 · https://doi.org/10.1038/ng.424

• Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

  Oncogene · 2008 · 10.1038/onc.2008.374

• An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.06.3743

• Genomic signatures to guide the use of chemotherapeutics

  Nature Medicine · 2006 · https://doi.org/10.1038/nm1491

• Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

  Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.04.144

• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  Nature · 2005 · https://doi.org/10.1038/nature04296

• Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon

  Clinical Cancer Research · 2005 · 10.1158/1078-0432.ccr-04-2509

• Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-04-0746

• Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

  Clinical Cancer Research · 2004 · 10.1158/1078-0432.ccr-03-0409

• PTEN/MMAC1 mutations in endometrial cancers.

  PubMed · 1997

• Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

  New England Journal of Medicine · 1996 · 10.1056/nejm199611073351901

• BRCA2 mutations in primary breast and ovarian cancers

  Nature Genetics · 1996 · https://doi.org/10.1038/ng0696-238

• BRCA1 Mutations in Primary Breast and Ovarian Carcinomas

  Science · 1994 · https://doi.org/10.1126/science.7939630

• Genetic instability of microsatellites in endometrial carcinoma.

  PubMed · 1993

• Overexpression and mutation of p53 in epithelial ovarian cancer.

  PubMed · 1991

• Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

  PubMed · 1990

Current projects

No projects listed.